Submission of Manufacturers and Manufacturing Operations to Product Management Service (PMS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 November 2024, 10:00 (CET) to 25 November 2024, 11:30 (CET)

Submitted by Anonymous (not verified) on 17 October 2024 - 10:53

Submission of Manufacturers and Manufacturing Operations to Product Management Service (PMS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 November 2024, 10:00 (CET) to 25 November 2024, 11:30 (CET)

Human medicines European public assessment report (EPAR): Gefitinib Mylan, gefitinib, Date of authorisation: 27/09/2018, Revision: 7, Status: Withdrawn (authorisation)

Submitted by Anonymous (not verified) on 17 October 2024 - 10:28

Human medicines European public assessment report (EPAR): Gefitinib Mylan, gefitinib, Date of authorisation: 27/09/2018, Revision: 7, Status: Withdrawn (authorisation)

Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 5 November 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 November 2024, 10:00 (CET) to 5 November 2024,

Submitted by Anonymous (not verified) on 17 October 2024 - 9:54

Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 5 November 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 November 2024, 10:00 (CET) to 5 November 2024, 10:30 (CET)

Q&A Clinic on Product Management Service (PMS) Product UI & API (3), Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 November 2024, 10:00 (CET) to 22 November 2024, 10:30 (CET)

Submitted by Anonymous (not verified) on 17 October 2024 - 9:39

Q&A Clinic on Product Management Service (PMS) Product UI & API (3), Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 November 2024, 10:00 (CET) to 22 November 2024, 10:30 (CET)

Veterinary medicines European public assessment report (EPAR): Purevax Rabies, rabies recombinant canarypox virus (vCP65), Status: Authorised

Submitted by Anonymous (not verified) on 17 October 2024 - 9:30

Veterinary medicines European public assessment report (EPAR): Purevax Rabies, rabies recombinant canarypox virus (vCP65), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Suvaxyn PRRS MLV, porcine respiratory and reproductive syndrome virus, live, Status: Authorised

Submitted by Anonymous (not verified) on 17 October 2024 - 8:53

Veterinary medicines European public assessment report (EPAR): Suvaxyn PRRS MLV, porcine respiratory and reproductive syndrome virus, live, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More